Vimarsana
Biggest News Aggregation in the World

Exclusive Option News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exclusive Option. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exclusive Option Today - Breaking & Trending Today

Update on Copper Silver Project | Company Announcement - Vimarsana News

Update on Copper Silver Project | Company Announcement

Investegate announcements from Update on Copper Silver Project

Biocytogen Pharmaceuticals Co., Ltd. Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma - Vimarsana News

Biocytogen Pharmaceuticals Co., Ltd. Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

Biocytogen Pharmaceuticals Co., Ltd. announced that it has entered into an Exclusive Option and License Agreement with Radiance Biopharma Inc. The agreement grants Radiance an option to license from...

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma - Vimarsana News

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

BEIJING & BOSTON, January 08, 2024--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces that it has entered into an Exclusive Option and License Agreement with Radiance Biopharma Inc. ("Radiance"), a biotechnology company specializing in developing next generation Antibody Drug Conjugates.

Source: yahoo.com
Pyx Resources Limited (NSX:PYX) Operations Update Q1 2023 - Vimarsana News

Pyx Resources Limited (NSX:PYX) Operations Update Q1 2023

PYX Resources Ltd (LON:PYX) (NSX:PYX), the world's second-largest publicly listed zircon producer by zircon resources, is pleased to provide an operational update for the three months ended 31 March 2023.

Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results - Vimarsana News

Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...